Literature DB >> 2669924

Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice.

C M Thumwood1, N H Hunt, W B Cowden, I A Clark.   

Abstract

A/J and CBA/H mice infected with Plasmodium berghei ANKA, a murine model of cerebral malaria, were used to see whether antioxidants influenced the outcome of this disease. Untreated, infected mice died 7 to 9 days after infection, often with cerebral symptoms. Haemorrhages, mononuclear infiltration and oedema were present in the central nervous system (CNS). Feeding a diet containing 0.75% (w/w) butylated hydroxyanisole (BHA) greatly altered the course of this disease. Death was delayed by up to 2 weeks and mice appeared healthy at parasitaemias that would have caused cerebral symptoms and death had they been on a conventional diet. BHA-fed mice showed few or no cerebral symptoms at a time at which control mice were clearly affected, and greatly reduced haemorrhages, mononuclear infiltration and oedema when the CNS was examined. Similar, but more consistent, protective effects were seen after administration of BHA by repeated injections or in osmotic pumps. The combination of superoxide dismutase and catalase, coupled to polyethylene glycol, when administered intravenously also protected mice against death from cerebral complications. Permeability of the blood-brain barrier was monitored by the use of 125I-labelled bovine serum albumin, 51Cr-labelled erythrocytes and the dye Evans blue, all of which are normally excluded from the CNS. Infected mice on control diet showed an increase in Evans blue staining and 125I and 51Cr retention in the CNS tissue itself. Feeding the diet containing BHA reduced these indices of increased blood-brain barrier permeability. In view of the potent radical scavenging activity of BHA in many other systems it is likely, but unproven, that this is its main role here. The protective effect of superoxide dismutase and catalase lends support to the idea that reactive oxygen species are involved in the pathology of experimental cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2669924      PMCID: PMC2040571     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  33 in total

1.  L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.

Authors:  G E Grau; P F Piguet; H D Engers; J A Louis; P Vassalli; P H Lambert
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Cerebral malaria in the United Kingdom.

Authors:  I Janota; B Doshi
Journal:  J Clin Pathol       Date:  1979-08       Impact factor: 3.411

4.  The effect of antithymocyte serum on golden hamsters and rats infected with Plasmodium berghei.

Authors:  D H Wright; R M Masembe; E R Bazira
Journal:  Br J Exp Pathol       Date:  1971-10

5.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

6.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

7.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

Authors:  N Sato; T Goto; K Haranaka; N Satomi; H Nariuchi; Y Mano-Hirano; Y Sawasaki
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

9.  Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

Authors:  I A Clark
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation.

Authors:  G Chaudhri; I A Clark; N H Hunt; W B Cowden; R Ceredig
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

View more
  17 in total

1.  Early microvascular changes in murine cerebral malaria detected in retinal wholemounts.

Authors:  T Chang-Ling; A L Neill; N H Hunt
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

2.  Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria.

Authors:  N Ma; N H Hunt; M C Madigan; T Chan-Ling
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections.

Authors:  S M Potter; A J Mitchell; W B Cowden; L A Sanni; M Dinauer; J B de Haan; N H Hunt
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

5.  Plasmodium falciparum Malaria: reduction of endothelial cell apoptosis in vitro.

Authors:  Christoph Josef Hemmer; Hans Anton Lehr; Kathi Westphal; Marcus Unverricht; Manja Kratzius; Emil Christian Reisinger
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes.

Authors:  I M Medana; N H Hunt; G Chaudhri
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

7.  N-acetylcysteine in severe falciparum malaria in Thailand.

Authors:  Sombat Treeprasertsuk; Srivicha Krudsood; Thanawat Tosukhowong; Wirach Maek-A-Nantawat; Suparp Vannaphan; Tosaporn Saengnetswang; Sornchai Looareesuwan; Walter F Kuhn; Gary Brittenham; James Carroll
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

8.  Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei.

Authors:  L M Kumaratilake; B S Robinson; A Ferrante; A Poulos
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.

Authors:  Prakaykaew Charunwatthana; M Abul Faiz; Ronnatrai Ruangveerayut; Richard J Maude; M Ridwanur Rahman; L Jackson Roberts; Kevin Moore; Emran Bin Yunus; M Gofranul Hoque; Mahatab Uddin Hasan; Sue J Lee; Sasithon Pukrittayakamee; Paul N Newton; Nicholas J White; Nicholas P J Day; Arjen M Dondorp
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.

Authors:  Ivo M B Francischetti; Emile Gordon; Bruna Bizzarro; Nidhi Gera; Bruno B Andrade; Fabiano Oliveira; Dongying Ma; Teresa C F Assumpção; José M C Ribeiro; Mirna Pena; Chen-Feng Qi; Ababacar Diouf; Samuel E Moretz; Carole A Long; Hans C Ackerman; Susan K Pierce; Anderson Sá-Nunes; Michael Waisberg
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.